Conason Q10 helps cancer and diabetes

Contained in the mitochondria vitamin-like substance Q10 conason became the object of research of an international group of scientists from Australia and the USA. They were able to establish that its use is an effective means of dealing with insulinrezistentnost tissues of the body.

The authors of the project, experts from the University of Sydney, University of New South Wales and Duke University, concluded that conason Q10 successfully fights with prediabetes – pre-diabetes a condition in which the blood sugar level increases and exceeds the norm.

The development of pre-diabetes, contributes to insulin resistance. Exploring features in the body of people with insulinrezistentnost, the researchers found that their fat and muscle mass people the levels of coenzyme Q10 decrease. Fill level of this substance, the experts have ensured that insulinrezistentnost tissue disappeared.

According to the researchers, the edible dietary Supplements with CoQ10 did not give the same effect, in this form it is poorly absorbed. They intend to develop the transport technology of coenzyme directly into the body.

Coenzyme Q10 (ubiquinone) was discovered in 1955. Contained in the mitochondria of cells, coenzyme plays a Central role in the cycle of chemical reactions, which delivers oxygen and energy production.

“Since CoQ10 is so successful in fighting with insulin resistance, replenishing its level can be an invaluable preventative measure for diseases such as type 2 diabetes, cardiovascular disease and even cancer and dementia,” said study co-author Professor Roland Stocker.